LENZ Therapeutics, Inc.(LENZ)

Biotechnology · Solana Beach, CA

$3.75+0.16 (+4.32%)

Delayed quote: Oct 6, 2026, 12:45 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T16:48:02.095Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:48:02.095Z.

Quote observation: 2026-10-06T16:45:32.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -113,908,000
Quote market capitalization: 117,422,206

FMP input reference: d8f500f051b8c2f6d9df2326c38ce0bcf8edb39987555b97daf7c0f1a95d0fd4

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LENZ Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

LENZ Competitors' Operating Cash Flow Yield

LENZ

LENZ Therapeutics, Inc.

Current

Market Cap

$117.42M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COYA

Coya Therapeutics, Inc.

vs LENZ

Market Cap

$117.17M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRBU

Caribou Biosciences, Inc.

vs LENZ

Market Cap

$116.54M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GNLX

Genelux Corporation

vs LENZ

Market Cap

$115.69M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCD

Lucid Diagnostics Inc.

vs LENZ

Market Cap

$115.59M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SEER

Seer, Inc.

vs LENZ

Market Cap

$121.23M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CBUS

Cibus, Inc.

vs LENZ

Market Cap

$121.37M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HURA

TuHURA Biosciences, Inc.

vs LENZ

Market Cap

$122.27M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENGN

enGene Holdings Inc.

vs LENZ

Market Cap

$121.25M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FHTX

Foghorn Therapeutics Inc.

vs LENZ

Market Cap

$112.73M

Operating Cash Flow Yield

N/A

TTM Avg

66.47%

3Y Avg

66.47%

5Y Avg

66.47%

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
LENZ Therapeutics, Inc. (LENZ)	$117.42M	N/A	N/A	N/A	N/A
Coya Therapeutics, Inc. (COYA)vs ›	$117.17M	N/A	N/A	N/A	N/A
Caribou Biosciences, Inc. (CRBU)vs ›	$116.54M	N/A	N/A	N/A	N/A
Genelux Corporation (GNLX)vs ›	$115.69M	N/A	N/A	N/A	N/A
Lucid Diagnostics Inc. (LUCD)vs ›	$115.59M	N/A	N/A	N/A	N/A
Seer, Inc. (SEER)vs ›	$121.23M	N/A	N/A	N/A	N/A
Cibus, Inc. (CBUS)vs ›	$121.37M	N/A	N/A	N/A	N/A
TuHURA Biosciences, Inc. (HURA)vs ›	$122.27M	N/A	N/A	N/A	N/A
enGene Holdings Inc. (ENGN)vs ›	$121.25M	N/A	N/A	N/A	N/A
Foghorn Therapeutics Inc. (FHTX)vs ›	$112.73M	N/A	66.47%	66.47%	66.47%

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

LENZ Operating Cash Flow Yield Metrics

LENZ Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics